ARTEMISMEDICARE / Q4-FY26 / risks

Keep the risk register visible.

Artemis Medicare Services · Material risks, their source context, and severity in the latest available quarter.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ4-FY26 · 2026-05-15Back to quarter ↗

Risk intelligence

Material risks this quarter

Raipur ramp-up losses and margin dilution

Raipur hospital expected to incur INR 18-20 crore losses in FY27, potentially dragging consolidated EBITDA margin by 1-1.5%.

medium

Regulatory risk from medical device margin caps

Analyst raised concern about health ministry examining margin caps on medical devices (30-50% range); management downplayed but acknowledged uncertainty.

medium

International patient volatility from geopolitical events

March saw 15-18% dip in international patients due to West Asia war; recovery underway but risk remains.

low

Cash flow conversion below EBITDA

Cash flow from operations at ~60% of EBITDA; analyst noted lower conversion in H2, though management attributed to normal operations.

low